Federal law allows compounding pharmacies to make copies of name brand drugs while there’s a supply shortage. But there's a ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Even the solid proposals set out by the Trump administration are being undermined by its actions taken elsewhere.

Novo Nordisk argues Medicare should negotiate the price for six of its insulin products separately, though they contain the ...

Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...

The Trump administration announced Friday it will not move forward with plans to cover popular weight-loss drugs under ...

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.

Independence Health Group, the parent company of Independence Blue Cross, spent $500 million last year to provide weight-control medications to its members.

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

In November, Mr. Biden set out to change that with a new rule that would drastically expand access to this type of medication ...

Typically, Medicare Part D will cover Ozempic to help manage blood sugar levels in adults with type 2 diabetes. Medicare does not cover Ozempic to treat prediabetes, which is an off-label use.